Literature DB >> 10820342

The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma.

S Shimaoka1, S Matsushita, T Nitanda, A Matsuda, T Nioh, T Suenaga, Y Nishimata, S Akiba, S Akiyama, H Nishimata.   

Abstract

BACKGROUND: Thymidine phosphorylase (TP) has angiogenic activity in various cancer tissues. Gastric carcinomas are classified into two histologic groups: differentiated and undifferentiated adenocarcinomas. There are differences in the modes of development and the extent of infiltration between the two groups. The purpose of the current study was to determine whether TP is involved in the invasiveness and progression of these two types of gastric carcinoma.
METHODS: To investigate the expression and localization of TP and the microvessel counts, the authors examined specimens from 149 gastric carcinoma patients. The specimens were stained using monoclonal antibody against TP and polyclonal antibody against factor VIII. To determine the cell type expressing TP, immunohistochemical staining using a monoclonal antibody against CD68 that is specific for macrophages and double staining using antibodies to both TP and CD68 were performed.
RESULTS: The proportion of TP positive tumors in differentiated adenocarcinomas was higher than that in undifferentiated adenocarcinomas. The TP positive differentiated adenocarcinomas invaded more deeply than the TP negative ones, but this was not the case with undifferentiated adenocarcinomas. TP was expressed mainly in the invasive edges of tumors and was expressed more frequently in macrophages than in tumor cells. TP expression was correlated with microvessel count and CD68 expression. Patients with TP positive carcinomas had a poorer prognosis than those with TP negative differentiated adenocarcinomas.
CONCLUSIONS: TP expressed in macrophages may be correlated with microvessel count and play an important role in tumor invasiveness and progression in differentiated gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820342

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.

Authors:  Akira Naruke; Mizutomo Azuma; Atsuko Takeuchi; Kenji Ishido; Chikatoshi Katada; Tohru Sasaki; Katsuhiko Higuchi; Satoshi Tanabe; Makoto Saegusa; Wasaburo Koizumi
Journal:  Gastric Cancer       Date:  2014-03-21       Impact factor: 7.370

2.  Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.

Authors:  Luciane Rostirola Cavazzola; Gustavo Franco Carvalhal; Candida Deves; Daiana Renck; Ricardo Almeida; DIóGENES Santiago Santos
Journal:  Oncol Lett       Date:  2015-04-01       Impact factor: 2.967

Review 3.  Angiogenesis in epithelian ovarian cancer.

Authors:  E S Bamberger; C W Perrett
Journal:  Mol Pathol       Date:  2002-12

4.  H pylori status and angiogenesis factors in human gastric carcinoma.

Authors:  Anita Mangia; Annalisa Chiriatti; Girolamo Ranieri; Ines Abbate; Maria Coviello; Giovanni Simone; Francesco Alfredo Zito; Severino Montemurro; Antonello Rucci; Alfredo Di Leo; Stefania Tommasi; Pasquale Berloco; Jian Ming Xu; Angelo Paradiso
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 5.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

6.  Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms.

Authors:  Shiladitya Sengupta; Lynda A Sellers; Hugh B Matheson; Tai-Ping D Fan
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

7.  Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.

Authors:  Misako Haraguchi; Hiroaki Tsujimoto; Masakazu Fukushima; Itsuro Higuchi; Hideto Kuribayashi; Hideo Utsumi; Atsuo Nakayama; Yoshio Hashizume; Junko Hirato; Hiroki Yoshida; Hiromitsu Hara; Shinjiro Hamano; Hiroaki Kawaguchi; Tatsuhiko Furukawa; Kohei Miyazono; Fuyuki Ishikawa; Hideo Toyoshima; Tadashi Kaname; Masaharu Komatsu; Zhe-Sheng Chen; Takenari Gotanda; Tokushi Tachiwada; Tomoyuki Sumizawa; Kazutaka Miyadera; Mitsuhiro Osame; Hiroki Yoshida; Tetsuo Noda; Yuji Yamada; Shin-ichi Akiyama
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix.

Authors:  P Kabuubi; J A Loncaster; S E Davidson; R D Hunter; C Kobylecki; I J Stratford; C M L West
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

9.  Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells.

Authors:  Sho Tabata; Ryuji Ikeda; Masatatsu Yamamoto; Shunji Shimaoka; Naofumi Mukaida; Yasuo Takeda; Katsushi Yamada; Tomoyoshi Soga; Tatsuhiko Furukawa; Shin-ichi Akiyama
Journal:  Oncotarget       Date:  2014-11-15

10.  The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer.

Authors:  Joung Soon Jang; Won Sup Lee; Jong Seok Lee; Hwal Woong Kim; Gyung Hyuck Ko; Woo Song Ha
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.